From a set of weakly potent lead compounds, using in silico screening and small library synthesis, a series of 2-alkyl-3-aryl-3-alkoxyisoindolinones has been identified as inhibitors of the MDM2-p53 interaction. Two of the most potent compounds, 2-benzyl-3-(4- chlorophenyl)-3-(3-hydroxypropoxy)-2, 3-dihydroisoindol-1-one (76; IC50= 15.9±0.8 μM) and 3-(4-chlorophenyl)-3-(4-hydroxy-3, 5-dimethoxybenzyloxy)-2-propyl-2, 3- ...
[Wyss, Daniel F.; Arasappan, Ashok; Senior, Mary M.; Wang, Yu-Sen; Beyer, Brian M.; Njoroge, F. George; McCoy, Mark A. Journal of Medicinal Chemistry, 2004 , vol. 47, # 10 p. 2486 - 2498]
[Wyss, Daniel F.; Arasappan, Ashok; Senior, Mary M.; Wang, Yu-Sen; Beyer, Brian M.; Njoroge, F. George; McCoy, Mark A. Journal of Medicinal Chemistry, 2004 , vol. 47, # 10 p. 2486 - 2498]
[Wyss, Daniel F.; Arasappan, Ashok; Senior, Mary M.; Wang, Yu-Sen; Beyer, Brian M.; Njoroge, F. George; McCoy, Mark A. Journal of Medicinal Chemistry, 2004 , vol. 47, # 10 p. 2486 - 2498]